Roche, Hitachi High-Tech extend IVD partnership

The partnership aims to drive innovation in in-vitro diagnostics to solve healthcare challenges of today and in the future

Hitachi High-Tech announced that its partnership with Roche has extended their partnership, committing to at least ten years of additional collaboration. 

The statement informs that the partnership will bring together the companies’ expertise and track record in diagnostics innovation, engineering and manufacturing, and further strengthen the two companies’ long-standing partnership.

It further informs that, the collaboration has resulted in a global reach of over 84,000 installed diagnostic units worldwide. Innovations have been made to the field of in-vitro diagnostics including the pioneering ‘serum work area’ concept that integrates clinical chemistry and immunochemistry into one system.

Both Roche and Hitachi High-Tech aim to drive innovation in in-vitro diagnostics to solve healthcare challenges of today and in the future.